MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia
eLife · 2023
DOI: 10.7554/elife.82597 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Courtney A Copeland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Brigham and Women's Hospital, Boston, United States. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Hypoxia requires metabolic adaptations to sustain energetically demanding cellular activities. While the metabolic consequences of hypoxia have been studied extensively in cancer cell models, comparatively little is known about how primary cell metabolism responds to hypoxia. Thus, we developed metabolic flux models for human lung fibroblast and pulmonary artery smooth muscle cells proliferating in hypoxia. Unexpectedly, we found that hypoxia decreased glycolysis despite activation of hypoxia-inducible factor 1α (HIF-1α) and increased glycolytic enzyme expression. While HIF-1α activation in normoxia by prolyl hydroxylase (PHD) inhibition did increase glycolysis, hypoxia blocked this effect. Multi-omic profiling revealed distinct molecular responses to hypoxia and PHD inhibition, and suggested a critical role for MYC in modulating HIF-1α responses to hypoxia. Consistent with this hypothesis, MYC knockdown in hypoxia increased glycolysis and MYC over-expression in normoxia decreased glycolysis stimulated by PHD inhibition. These data suggest that MYC signaling in hypoxia uncouples an increase in HIF-dependent glycolytic gene transcription from glycolytic flux.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Brigham and Women's Hospital, Boston, United States.
- Department of Medicine, Harvard Medical School, Boston, United States.
- Department of Medicine, Massachusetts General Hospital, Boston, United States.
- Center for Systems Biology, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
- Departments of Chemical & Biomolecular Engineering and Molecular Physiology & Biophysics, Vanderbilt University, Nashville, United States.
ORCID-Profile: Joseph Loscalzo, William M Oldham
Förderung
- NHLBI NIH HHS
- NIH HHS
- NHGRI NIH HHS
- National Institutes of Health
- American Lung Association
- Pulmonary Hypertension Association
- American Thoracic Society
- American Heart Association
Zitieren
APA
Copeland, C. A., Olenchock, B. A., Ziehr, D., McGarrity, S., Leahy, K., Young, J. D., Loscalzo, J., & Oldham, W. M. (2023). MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia. eLife. https://doi.org/10.7554/elife.82597
Vancouver
Copeland CA, Olenchock BA, Ziehr D, McGarrity S, Leahy K, Young JD, et al. MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia. eLife. 2023. doi:10.7554/elife.82597
BibTeX
@article{Copeland2023,
author = {Copeland, Courtney A and Olenchock, Benjamin A and Ziehr, David and McGarrity, Sarah and Leahy, Kevin and Young, Jamey D and Loscalzo, Joseph and Oldham, William M},
title = {MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.82597}
}
EUVIMED